Agios Pharmaceuticals (AGIO) Gross Margin (2017 - 2026)
Agios Pharmaceuticals (AGIO) posted Gross Margin of 93.64% for Q1 2026, up 3.37% on a QoQ basis from 90.59% in Q4 2025, and up 608.0% year-over-year from 13.23% in Q1 2025.
Agios Pharmaceuticals (AGIO) Gross Margin (2017 - 2026) Analysis & Trends
Agios Pharmaceuticals' Gross Margin history runs 9 years deep, the most recent figure standing at 93.64% for Q1 2026.
- Quarterly Gross Margin rose 608.0% year-over-year to 93.64% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 90.04% (up 252.0% YoY) and the FY2025 annual result came in at 88.26%, down 33.0% from the prior year.
- Gross Margin was 93.64% for Q1 2026 at Agios Pharmaceuticals, up from 90.59% in the prior quarter.
- Across five years, Gross Margin topped out at 93.64% in Q1 2026 and bottomed at 59.25% in Q1 2022.
- A 5-year average of 87.27% and a median of 90.12% in 2023 frame the typical range for Gross Margin.
- Peak annual rise in Gross Margin reached 3087 bps in 2023, while the deepest fall reached 871 bps in 2023.
- Agios Pharmaceuticals' Gross Margin stood at 90.42% in 2022, then climbed by 1 bps to 91.75% in 2023, then decreased by 4 bps to 88.26% in 2024, then climbed by 3 bps to 90.59% in 2025, then climbed by 3 bps to 93.64% in 2026.
- Business Quant data shows AGIO's Gross Margin at 93.64% in Q1 2026, 90.59% in Q4 2025, and 86.96% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 93.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.64% |
| Dec 31, 2025 | 90.59% |
| Sep 30, 2025 | 86.96% |
| Jun 30, 2025 | 86.33% |
| Mar 31, 2025 | 87.57% |
| Dec 31, 2024 | 88.26% |
| Sep 30, 2024 | 91.27% |
| Jun 30, 2024 | 82.65% |
| Mar 31, 2024 | 92.34% |
| Dec 31, 2023 | 91.75% |
| Sep 30, 2023 | 91.44% |
| Jun 30, 2023 | 83.49% |
| Mar 31, 2023 | 90.12% |
| Dec 31, 2022 | 90.42% |
| Sep 30, 2022 | 85.30% |
| Jun 30, 2022 | 92.21% |
| Mar 31, 2022 | 59.25% |
| Dec 31, 2020 | 104.19% |
| Sep 30, 2020 | 98.16% |
| Jun 30, 2020 | 98.19% |